Abstract:Prevention is one of the most important and promising strategies to control cancer. Many dietary bioactive compounds, mostly phytochemicals, have been found to decrease the risk of carcinogenesis. Modulating the metabolism and disposition pathways of carcinogens represents one of the major mechanisms by which dietary compounds prevent carcinogenesis. In the present review, the specific molecular targets of dietary compounds within carcinogen metabolism, including various enzymes and transporters and their regulatory signaling pathways, are briefly reviewed. The expression of phase I enzymes, which presumably mostly activate carcinogens, is mainly regulated by xenobiotics sensing nuclear receptors such as AhR, CAR, PXR, and RXR. On the other hand, phase II enzymes catalyze the conjugations of carcinogens and generally are transcriptionally controlled by the Nrf2/ARE signaling pathways. The Nrf2/ARE signaling pathway, which regulates the expression of many detoxifying enzymes, is a major target of dietary compounds. The final excretion of carcinogens and their metabolites is mediated by phase III transporters, which share many regulatory mechanisms with phase I/II enzymes. Indeed, the expression of metabolizing enzymes and transporters is often coordinately regulated. Besides transcriptional regulation, the activities of phase I/II enzymes and phase III transporters could be directly activated or inhibited by dietary compounds. Furthermore, genetic polymorphisms have profound effects on the individual response to dietary compounds. Finally, the effects of cancer prevention and the risk of carcinogenesis are determined by the network composed of known/unknown molecular targets and signaling pathways and its interaction with various xenobiotics, including carcinogens, drugs, and diet. With the rapid advances in the post genomic sciences, it could be possible to decipher this network and better predict the clinical outcomes of cancer prevention by dietary bioactive compounds.

The Oral Dipeptidyl-Peptidase-4 Inhibitor Sitagliptin Increases Circulating Levels Of Stromal-Derived Factor-1 Alpha

Cancer Prevention by Epigenetic Modulation of Phytochemicals

Fluorescent Cytometric Analysis of Polymorphonuclear Leukocytes in Chediak-Higashi Syndrome: Diminished C3bi Receptor Expression (OKM1) with Normal Granular Cell Density

Barriers to the collaborative care of patients with orofacial injury.

Dietary Phytochemicals as Epigenetic Modulators in Cancer Prevention: Emerging Research Trends, Gaps, and Future Perspectives

Nutritional Epigenetics and Phytochemicals in Cancer Formation

A Review on some dietary phytochemicals as potential cancer chemoprevention and chemotherapeutic agents

Cancer Chemoprevention by Phytochemicals: Potential Molecular Targets, Biomarkers and Animal Models

Extractive photometric determination of thorium with arsenazo DAL.

Prediction of Number Born Alive and Weaning Weight of Litter in First Parity Sows Using Performance Test Traits in Four Breeds of Swine

Modulation of Key Signaling Pathways in Cancer Cells by Dietary Factors

Phytochemicals in Traditional Chinese Herbal Medicine: Cancer Prevention and Epigenetics Mechanisms

Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment

Targeting Carcinogen Metabolism by Dietary Cancer Preventive Compounds

Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention

Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer

Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression

Tension pneumothorax during flexible fiberoptic bronchoscopy in a newborn.

Effects of Dietary Phytochemicals on DNA Damage in Cancer Cells

[Nrf2 As a Chemoprevention Target in Gastrointestinal Carcinoma].

Cancers chemoprevention by dietary phytochemicals and traditional Chinese medicines: epigenetics and cellular signaling pathways